A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma-Reference-Cited by-同舟云学术

A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma

Published:2017-06-05 Issue:10 Volume:52 Page:1378-1383
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Franssen L E,Roeven M W H,Hobo W,Doorn R,Oostvogels R,Falkenburg J H F,van de Donk N W,Kester M G D,Fredrix H,Westinga K,Slaper-Cortenbach I,Spierings E^ORCID,Kersten M J,Dolstra H,Mutis T,Schaap N,Lokhorst H M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2017118.pdf

Reference29 articles.

1. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041–2050.

2. Goulmy E . Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997; 157: 125–140.

3. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415.

4. Mapara MY, Kim Y-M, Wang S-P, Bronson R, Sachs DH, Sykes M . Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 2002; 100: 1903–1909.

5. Broen K, Greupink-Draaisma A, Fredrix H, Schaap N, Dolstra H . Induction of multiple myeloma-reactive T cells during post-transplantation immunotherapy with donor lymphocytes and recipient DCs. Bone Marrow Transplant 2012; 47: 1229–1234.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation;Blood;2024-09-05

2. Minor histocompatibility antigens to predict, monitor or manipulate GvL and GvHD after allogeneic hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-06

3. Association Between Human Leukocyte Antigens and Graft-Versus-Host Disease Occurrence in Allogeneic Hematopoietic Stem Cell Transplantation – A 10-Year Experience on Iranian Patients;Archives of Iranian Medicine;2022-12-01

4. Dendritic Cell Differentiation from Human Induced Pluripotent Stem Cells: Challenges and Progress;Stem Cells and Development;2022-05-01

5. Minor histocompatibility antigens as targets for T-cell immunotherapy;Russian journal of hematology and transfusiology;2021-10-25